
Teleflex has positive Arrow catheter data
Teleflex (NYSE: TFX) + reports new findings from a study showing the efficacy of its Arrow chlorhexidine-impregnated central venous catheters (CVCs). The prospective study cohort included more than 6,670 patients from 12 intensive care units (ICUs). It …